Sökresultat - Marco Capobianco

Förfina resultatet
  1. 1
    Aquaporin-4 antibody titration in NMO patients treated with rituximab

    Aquaporin-4 antibody titration in NMO patients treated with rituximab av Paola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Concomitant brain arterial and venous thrombosis in a COVID‐19 patient

    Concomitant brain arterial and venous thrombosis in a COVID‐19 patient av Maria Malentacchi, Dario Gned, Valeria Angelino, S. Demichelis, Alberto Perboni, Andrea Veltri, Antonio Bertolotto, Marco Capobianco

    Publicerad 2020
    Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  3. 3
    Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers

    Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers av Marianna Lo Re, Marco Capobianco, Paolo Ragonese, Sabrina Realmuto, Simona Malucchi, Paola Berchialla, Giuseppe Salemi, Antonio Bertolotto

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders

    Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders av Andrea Marcinnò, Fabiana Marnetto, Paola Valentino, Serena Martire, Alessia Balbo, Aurora Drago, Maria Rita Leto, Marco Capobianco, Giancarlo Panzica, Antonio Bertolotto

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews

    Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews av Ju‐Hong Min, Marco Capobianco, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Aurélio Lana–Peixoto, Dean M. Wingerchuk, Jiawei Wang, Marius Ringelstein

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews

    Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews av Marco Capobianco, Marius Ringelstein, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Marco Aurélio Lana–Peixoto, Jiawei Wang, Ju‐Hong Min, Dean M. Wingerchuk

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis

    Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis av Francesca Gilli, Raija L.P. Lindberg, Paola Valentino, Fabiana Marnetto, Simona Malucchi, Arianna Sala, Marco Capobianco, Alessia Di Sapio, Francesca Sperli, Ludwig Kappos, Raffaele Calogero, Antonio Bertolotto

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

    Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis av Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Lucia Moiola, Marta Radaelli, Paolo Immovilli, Marco Capobianco, María Trojano, Paola Zaratin, Gioacchino Tedeschi, Gıancarlo Comı, Mario Alberto Battaglia, Francesco Patti, Marco Salvetti

    Publicerad 2021
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis

    Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis av Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Lucia Moiola, Marta Radaelli, Paolo Immovilli, Marco Capobianco, María Trojano, Paola Zaratin, Gioacchino Tedeschi, Giancarlo Comi, Mario Alberto Battaglia, Francesco Patti, Marco Salvetti, Musc- Study Group

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

    Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone av V. Martinelli, Eleonora Cocco, Ruggero Capra, Giuseppe Salemi, Paolo Gallo, Marco Capobianco, Ilaria Pesci, A. Ghezzi, Carlo Pozzilli, Alessandra Lugaresi, P. Bellantonio, Maria Pia Amato, L. M. E. Grimaldi, María Trojano, Gianluigi Mancardi, Roberto Bergamaschi, Claudio Gasperini, M. Rodegher, Laura Straffi, Michela Ponzio, Gıancarlo Comı

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

    E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders av Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, Frederik Bartels, Carsten Finke, Markus Breu, Lorraine Flet‐Berliac, Aliénor de Chalus, C. Adamsbaum, Marco Capobianco, Laetitia Giorgi, Yael Hacohen, Cheryl Hemingway, Evangeline Wassmer, Ming Lim, Matthias Baumann, Ronny Wickström, Thaís Armangué, Kevin Rostásy, Kumaran Deiva, Rinze F. Neuteboom

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  12. 12
    E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

    E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders av Matthias Baumann, Frederik Bartels, Carsten Finke, C. Adamsbaum, Yael Hacohen, Kevin Rostásy, E.U. paediatric Mog consortium, Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, Markus Breu, Lorraine Flet‐Berliac, Aliénor de Chalus, Marco Capobianco, Laetitia Giorgi, Cheryl Hemingway, Evangeline Wassmer, Ming Lim, Ronny Wickström, Thaís Armangué, Kumaran Deiva, Rinze F. Neuteboom

    Publicerad 2020
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  13. 13
    E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

    E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders av Arlette L. Bruijstens, Christian Lechner, Lorraine Flet‐Berliac, Kumaran Deiva, Rinze F. Neuteboom, Cheryl Hemingway, Evangeline Wassmer, E.U. paediatric Mog consortium, Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, Markus Breu, Lorraine Flet‐Berliac, Aliénor de Chalus, Marco Capobianco, Laetitia Giorgi, Cheryl Hemingway, Evangeline Wassmer, Ming Lim, Ronny Wickström, Thaís Armangué, Kumaran Deiva, Rinze F. Neuteboom

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  14. 14
    E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

    E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders av Arlette L. Bruijstens, Markus Breu, Eva‐Maria Wendel, Evangeline Wassmer, Ming Lim, Rinze F. Neuteboom, Ronny Wickström, E.U. paediatric Mog consortium, Arlette L. Bruijstens, Eva‐Maria Wendel, Christian Lechner, Markus Breu, Lorraine Flet‐Berliac, Aliénor de Chalus, Marco Capobianco, Laetitia Giorgi, Cheryl Hemingway, Evangeline Wassmer, Ming Lim, Ronny Wickström, Thaís Armangué, Kumaran Deiva, Rinze F. Neuteboom

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  15. 15
    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with... av Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W. Hümmert, Corinna Trebst, Marius Ringelstein, Orhan Aktaş, Alexander Winkelmann, Mathias Buttmann, Alexander Schwarz, Hanna Zimmermann, Alexander U. Brandt, Diego Franciotta, Marco Capobianco, Joseph Kuchling, Jürgen Haas, Mirjam Korporal‐Kuhnke, Søren Thue Lillevang, Kaï Fechner, Kathrin Schanda, Friedemann Paul, Brigitte Wildemann, Markus Reindl

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Treatment and outcome of aquaporin-4 antibody–positive NMOSD

    Treatment and outcome of aquaporin-4 antibody–positive NMOSD av Renata Barbosa Paolilo, Yael Hacohen, Elise Yazbeck, Thaís Armangué, Arlette L. Bruijstens, Christian Lechner, Samira Luísa Apóstolos‐Pereira, Yana Martynenko, Markus Breu, Carolina de Medeiros Rimkus, Evangeline Wassmer, Matthias Baumann, Laura Papetti, Marco Capobianco, Barbara Kornek, Kevin Rostásy, José Albino da Paz, Olga Ciccarelli, Ming Lim, Albert Saiz, Rinze F. Neuteboom, Romain Marignier, Cheryl Hemingway, Douglas Kazutoshi Sato, Kumaran Deiva

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, an... av Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W. Hümmert, Marius Ringelstein, Corinna Trebst, Alexander Winkelmann, Alexander Schwarz, Mathias Buttmann, Hanna Zimmermann, Joseph Kuchling, Diego Franciotta, Marco Capobianco, Eberhard Siebert, Carsten Lukas, Mirjam Korporal‐Kuhnke, Jürgen Haas, Kaï Fechner, Alexander U. Brandt, Kathrin Schanda, Orhan Aktaş, Friedemann Paul, Markus Reindl, Brigitte Wildemann

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

    Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies av Pietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, Damiano Paolicelli, Francesco Patti, Mauro Zaffaroni, Vincenzo Brescia Morra, Carlo Pozzilli, Giovanna De Luca, Matilde Inglese, Giuseppe Salemi, Giorgia Teresa Maniscalco, Eleonora Cocco, Patrizia Sola, Giacomo Lus, Antonella Conte, Maria Pia Amato, Franco Granella, Claudio Gasperini, Paolo Bellantonio, Rocco Totaro, Marco Rovaris, Marco Salvetti, Valentina Torri Clerici, Roberto Bergamaschi, Davide Maimone, Elio Scarpini, Marco Capobianco, Gıancarlo Comı, Massimo Filippi, María Trojano

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France

    DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France av Maria Pia Sormani, Marco Salvetti, Pierre Labauge, Irene Schiavetti, Hélène Zephir, Luca Carmisciano, Caroline Bensa, Nicola De Rossi, Jean Pelletier, Cinzia Cordioli, Sandra Vukusic, Lucia Moiola, Philippe Kerschen, Marta Radaelli, Marie Théaudin, Paolo Immovilli, Olivier Casez, Marco Capobianco, Jonathan Ciron, María Trojano, Bruno Stankoff, Alain Créange, Gioacchino Tedeschi, Pierre Clavelou, Gıancarlo Comı, Éric Thouvenot, Mario Alberto Battaglia, Thibault Moreau, Francesco Patti, de Sèze, Céline Louapre

    Publicerad 2021
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

    Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients av Sven Jarius, Florence Pache, Peter Körtvélyessy, Ilijas Jelčić, Mark Stettner, Diego Franciotta, E. Keller, Bernhard Neumann, Marius Ringelstein, Makbule Şenel, Axel Regeniter, Rea Kalantzis, Jan Willms, Achim Berthele, Markus Busch, Marco Capobianco, Amanda Eisele, Ina Reichen, Rick Dersch, Sebastian Rauer, Katharina Sandner, Ilya Ayzenberg, Catharina C. Groß, Harald Hegen, Michael Khalil, Ingo Kleiter, Thorsten Lenhard, Jürgen Haas, Orhan Aktaş, Klemens Angstwurm, Christoph Kleinschnitz, Jan Lewerenz, Hayrettin Tumani, Friedemann Paul, Martin Stangel, Klemens Ruprecht, Brigitte Wildemann

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: